🇺🇸 FDA
Patent

US 11554168

HIV vaccines comprising one or more population episensus antigens

granted A61KA61K2039/53A61K2039/70

Quick answer

US patent 11554168 (HIV vaccines comprising one or more population episensus antigens) held by Vir Biotechnology, Inc. expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vir Biotechnology, Inc.
Grant date
Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/53, A61K2039/70, A61K39/12, A61K39/21